Robust antitumor treatment driven by lock-and-key biorecognition of dynamic cyclic diselenide-guided chiral prodrug self-assembly

Yixin Sun, Baoyuan Zhang, Jiayao Wang, Xin Li, Zhonggui He, Chutong Tian, Bingjun Sun, Jin Sun

Open source

DOI
10.1016/j.chembiol.2025.07.003
Published
2025-08
Container
Cell Chemical Biology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.chembiol.2025.07.003,
  title = {Robust antitumor treatment driven by lock-and-key biorecognition of dynamic cyclic diselenide-guided chiral prodrug self-assembly},
  author = {Yixin Sun and Baoyuan Zhang and Jiayao Wang and Xin Li and Zhonggui He and Chutong Tian and Bingjun Sun and Jin Sun},
  year = {2025},
  journal = {Cell Chemical Biology},
  doi = {10.1016/j.chembiol.2025.07.003},
  url = {https://doi.org/10.1016/j.chembiol.2025.07.003}
}

RIS

TY  - JOUR
TI  - Robust antitumor treatment driven by lock-and-key biorecognition of dynamic cyclic diselenide-guided chiral prodrug self-assembly
AU  - Yixin Sun
AU  - Baoyuan Zhang
AU  - Jiayao Wang
AU  - Xin Li
AU  - Zhonggui He
AU  - Chutong Tian
AU  - Bingjun Sun
AU  - Jin Sun
PY  - 2025
JO  - Cell Chemical Biology
DO  - 10.1016/j.chembiol.2025.07.003
UR  - https://doi.org/10.1016/j.chembiol.2025.07.003
ER  - 

APA

Sun, Y., Zhang, B., Wang, J., Li, X., He, Z., Tian, C., Sun, B., & Sun, J. (2025). Robust antitumor treatment driven by lock-and-key biorecognition of dynamic cyclic diselenide-guided chiral prodrug self-assembly. Cell Chemical Biology. https://doi.org/10.1016/j.chembiol.2025.07.003

Source records